摘要
目的 探讨急性心肌梗死 (AMI)尿激酶溶栓组和非溶栓组患者预后和QT离散度 (QTd)的变化。方法 比较溶栓组 ( 94例 )和非溶栓组 ( 3 2例 )患者心脏事件、左室功能、室性心律失常和QTd的改变。结果 心脏事件的发生率溶栓组低于非溶栓组 ,左室功能溶栓组和非溶栓组分别为 ( 5 1 8± 7 2 ) %及 ( 3 6 8± 7 0 ) % ,室性心律失常分别为 ( 15± 6) %及 ( 2 6± 10 ) % ,d 2QTd分别为 ( 4 2 78± 14 84)ms及 ( 5 6 84± 19 18)ms。结论 溶栓治疗AMI是安全的 ,能改善患者的预后。
Objective To study the effects of urokinase thrombolytic therapy on the prognosis and QTd of patients with acute myocardial infarction(AMI).Methods\ The incidence of cardiac events,left ventricular function,ventricular arrhythmia and QTd were analysed and compared between thrombolytic group (94 cases) and non-thrombolytic group (32 cases) of AMI patients.Results\ The incidence of cardiac events in thrombolytic group was lower than that in non-thrombolytic group. Left ventricular function, incidence of arrhythmia and day 2 QTd in thrombolytic and non-thrombolytic group were (51 8±7 2)% vs (36 8±7 0)%, (15±6)% vs (26±10)% and (42 78±14 84)ms vs (56 84±19 18)ms, respectively. Conclusion\ Thrombolysis using urokinase is safe and can improve prognosis of AMI.
出处
《广东医学》
CAS
CSCD
2000年第6期460-461,共2页
Guangdong Medical Journal
